148 related articles for article (PubMed ID: 34619749)
21. Frequency, predictors and prognostic impact of implantable cardioverter defibrillator shocks in a primary prevention population with heart failure and reduced ejection fraction.
Masini M; Elia E; Vianello PF; Bertero G; Rossi P; Ameri P; Chiarella F; Brunelli C; Porto I; Sartori P; Canepa M
J Cardiovasc Med (Hagerstown); 2021 Feb; 22(2):118-125. PubMed ID: 32941323
[TBL] [Abstract][Full Text] [Related]
22. Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.
Briongos-Figuero S; Estévez A; Luisa Pérez M; Martínez-Ferrer JB; García E; Viñolas X; Arenal Á; Alzueta J; Basterra N; Rodríguez A; Lozano I; Muñoz-Aguilera R
Int J Cardiol; 2019 Jan; 274():163-169. PubMed ID: 30206014
[TBL] [Abstract][Full Text] [Related]
23. Subcutaneous implantable cardioverter-defibrillator: a systematic review of comparative effectiveness and safety.
Wolf S; Götz G; Wernly B; Wild C
ESC Heart Fail; 2023 Apr; 10(2):808-823. PubMed ID: 36444868
[TBL] [Abstract][Full Text] [Related]
24. The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study.
Bhavnani SP; Pavuluri V; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
Pacing Clin Electrophysiol; 2013 Jul; 36(7):878-84. PubMed ID: 23614760
[TBL] [Abstract][Full Text] [Related]
25. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C
Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686
[TBL] [Abstract][Full Text] [Related]
26. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?
Koyak Z; de Groot JR; Van Gelder IC; Bouma BJ; van Dessel PF; Budts W; van Erven L; van Dijk AP; Wilde AA; Pieper PG; Sieswerda GT; Mulder BJ
Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):101-10. PubMed ID: 22095638
[TBL] [Abstract][Full Text] [Related]
27. Association of Implantable Cardioverter Defibrillator Therapy with All-Cause Mortality-A Systematic Review and Meta-Analysis.
Qian Z; Zhang Z; Guo J; Wang Y; Hou X; Feng G; Zou J
Pacing Clin Electrophysiol; 2016 Jan; 39(1):81-8. PubMed ID: 26470761
[TBL] [Abstract][Full Text] [Related]
28. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial.
Gold MR; Lambiase PD; El-Chami MF; Knops RE; Aasbo JD; Bongiorni MG; Russo AM; Deharo JC; Burke MC; Dinerman J; Barr CS; Shaik N; Carter N; Stoltz T; Stein KM; Brisben AJ; Boersma LVA;
Circulation; 2021 Jan; 143(1):7-17. PubMed ID: 33073614
[TBL] [Abstract][Full Text] [Related]
29. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.
Gupta A; Harrington M; Albert CM; Bajaj NS; Hainer J; Morgan V; Bibbo CF; Bravo PE; Osborne MT; Dorbala S; Blankstein R; Taqueti VR; Bhatt DL; Stevenson WG; Di Carli MF
JACC Clin Electrophysiol; 2018 Sep; 4(9):1200-1210. PubMed ID: 30236394
[TBL] [Abstract][Full Text] [Related]
30. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.
Madhavan M; Waks JW; Friedman PA; Kramer DB; Buxton AE; Noseworthy PA; Mehta RA; Hodge DO; Higgins AY; Webster TL; Witt CM; Cha YM; Gersh BJ
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003283. PubMed ID: 26921377
[TBL] [Abstract][Full Text] [Related]
31. Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients.
Blom LJ; Visser M; Christiaans I; Scholten MF; Bootsma M; van den Berg MP; Yap SC; van der Heijden JF; Doevendans PA; Loh P; Postema PG; Barge-Schaapsveld DQ; Hofman N; Volders PGA; Wilde AA; Hassink RJ
Europace; 2019 Oct; 21(10):1519-1526. PubMed ID: 31114860
[TBL] [Abstract][Full Text] [Related]
32. Subcutaneous implantable cardioverter-defibrillator: is it ready for use in children and young adults? A single-centre study.
Silvetti MS; Pazzano V; Verticelli L; Battipaglia I; Saputo FA; Albanese S; Lovecchio M; Valsecchi S; Drago F
Europace; 2018 Dec; 20(12):1966-1973. PubMed ID: 29939256
[TBL] [Abstract][Full Text] [Related]
33. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes.
Santharam S; Hudsmith L; Thorne S; Clift P; Marshall H; De Bono J
Europace; 2017 Mar; 19(3):407-413. PubMed ID: 27234868
[TBL] [Abstract][Full Text] [Related]
35. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
36. Clinical Impact of Implantable Cardioverter-Defibrillator Therapy and Mortality Prediction Model for Effective Primary Prevention in Korean Patients.
Bae MH; Cho Y; Hwang J; Park HS; Han S; Lee YS; Cho HJ; Jung BC; Lee CH; Hyun DW; Park JS; Ahn J; Kim KH; Shin DG
J Korean Med Sci; 2020 Mar; 35(9):e49. PubMed ID: 32141247
[TBL] [Abstract][Full Text] [Related]
37. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy.
Grimm W; Flores BT; Marchlinski FE
Circulation; 1993 Jun; 87(6):1880-8. PubMed ID: 8504500
[TBL] [Abstract][Full Text] [Related]
38. Benefit of Implantable Cardioverter-Defibrillator Generator Replacement in a Primary Prevention Population-Based Cohort.
Weng W; Sapp J; Doucette S; MacIntyre C; Gray C; Gardner M; Abdelwahab A; Parkash R
JACC Clin Electrophysiol; 2017 Oct; 3(10):1180-1189. PubMed ID: 29759503
[TBL] [Abstract][Full Text] [Related]
39. Automated electrocardiographic quantification of myocardial scar in patients undergoing primary prevention implantable cardioverter-defibrillator implantation: Association with mortality and subsequent appropriate and inappropriate therapies.
Reichlin T; Asatryan B; Vos MA; Willems R; Huikuri HV; Junttila MJ; Schlögl SC; Hnatkova K; Schaer BA; Malik M; Zabel M; Sticherling C;
Heart Rhythm; 2020 Oct; 17(10):1664-1671. PubMed ID: 32428669
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
